Please login to the form below

Not currently logged in
Email:
Password:

EU

This page shows the latest EU news and features for those working in and with pharma, biotech and healthcare.

NICE leaves the ‘the NHS door’ open despite rejecting Bayer’s Vitrakvi

NICE leaves the ‘the NHS door’ open despite rejecting Bayer’s Vitrakvi

Rozyltrek won FDA approval in August, and is currently being reviewed for approval in the EU. ... Although Bayer has had a head start in the EU market, it could see its progress derailed because of Roche’s willingness to compete on price.

Latest news

More from news
Approximately 133 fully matching, plus 2,061 partially matching documents found.

Latest Intelligence

  • A snapshot of Microbiotica A snapshot of Microbiotica

    What impact will Brexit have on the business? A very large proportion of our staff are continental EU citizens and it has been a major recruitment source. ... At Cambridge University, 25% of its staff are continental EU citizens.

  • Strengthening business competition and reducing anti-competitive practices Strengthening business competition and reducing anti-competitive practices

    And it seems to have worked. In the ten years following the publication of the report, national authorities across the EU have imposed fines amounting to over 1bn. ... Under EU law, the public authorities responsible for granting public contracts have a

  • Delivering the promise of regenerative medicine Delivering the promise of regenerative medicine

    The effect of Brexit on the UK’s regenerative medicine sector remains unclear, but the UK has the opportunity to develop an independent framework outside the EU regulatory system to accelerate ... In any case, EU and UK regulators need to prioritise

  • Assessing the risks in annuity pricing models Assessing the risks in annuity pricing models

    Throughout the EU, reimbursement for cell and gene therapies is often limited and inconsistent, and an analysis conducted by the Life Sciences Practice team at CRA, the global consulting firm, found

  • A snapshot of Crescendo Biologics A snapshot of Crescendo Biologics

    Continental EU citizens have been a major source of recruitment for us.

More from intelligence
Approximately 8 fully matching, plus 178 partially matching documents found.

Latest appointments

More from appointments
Approximately 2 fully matching, plus 59 partially matching documents found.

Latest from PMHub

More from PMHub
Approximately 3 fully matching, plus 120 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Create Health

A healthcare marketing agency that shares your passion for making things better. Our clients with solve real health problems every...

Latest intelligence

How do companies prepare for reimbursement?
Valid Insight explore how to optimise your market access strategy during new product development, how to address payer concerns and prepare for reimbursement....
EHR clinical trials
Integrating electronic health records into clinical trials
How organisations are working to realise the research potential of EHRs...
Mike Elliott Gilead
Keeping up the fight against HIV and using the lessons to tackle other threats
Danny Buckland interviews Gilead’s Mike Elliott...

Infographics